Keyphrases
In Cancer
100%
Therapeutic Targeting
100%
Epigenetic Regulators
100%
MLL3
100%
Metabolic Vulnerability
100%
Purine Synthesis
37%
MLL4
25%
Mouse Embryonic Stem Cells (mESCs)
25%
Lometrexol
25%
Human Disease
12%
RNA Sequencing (RNA-seq)
12%
Tumor
12%
Family Members
12%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
12%
Gene Signature
12%
Epigenetics
12%
KO Mice
12%
Vulnerability
12%
Functional Outcome
12%
Highly Sensitive
12%
Metabolic Activity
12%
Enhanced Sensitivity
12%
Nucleotide Synthesis
12%
Epigenetic Modification
12%
Mouse Tumor Model
12%
Epigenetic Factors
12%
Synthetic Lethality
12%
Molecular Insight
12%
MLL1
12%
Enhancer Activity
12%
Synthesis Pathway
12%
Purine Metabolism
12%
Proteomic Profiling
12%
TMT Proteomics
12%
Unique Genes
12%
Metabolic Dependencies
12%
Purine nucleotides
12%
Factor Deficiency
12%
Chromatin-modifying Enzymes
12%
Pyrimidine nucleotides
12%
Dropout Screen
12%
Biochemistry, Genetics and Molecular Biology
Epigenetics
100%
MLL3
100%
Purine Synthesis
37%
Embryonic Stem Cell
25%
MLL4
25%
Gene Expression Profiling
12%
RNA Sequencing
12%
Animal Models
12%
Enzyme
12%
Proteomics
12%
Knockout Mouse
12%
CRISPR
12%
Upregulation
12%
Enhancer Region
12%
Nucleotide Metabolism
12%
Tandem Mass Tag
12%
Purine Metabolism
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Purine
100%
Lometrexol
50%
Knockout Mouse
25%
Lethality
25%
Purine Nucleotide
25%
Pyrimidine Nucleotide
25%
Disease
25%
Neoplasm
25%